Pyrimido pyrimidinone compound and pharmaceutical composition comprising the same
Summary
The USPTO granted Patent US12590098B2 to Axceso Biopharma Co., Ltd. on March 31, 2026, covering a pyrimido pyrimidinone compound that inhibits PD-L1 expression for cancer treatment. The patent includes 9 claims and names 8 inventors including Young Jun Park and Sung Jun Park.
What changed
USPTO granted Patent US12590098B2 to Axceso Biopharma Co., Ltd. for a pyrimido pyrimidinone compound effective as a PD-L1 inhibitor for cancer treatment or prevention. The patent (Application No. 18245395, filed September 15, 2021) contains 9 claims and is classified under CPC C07D 487/04.
No immediate compliance action is required by regulated entities. This is a routine patent grant that establishes intellectual property rights for the assignee. Third parties seeking to use or develop similar compounds should conduct freedom-to-operate analyses and respect the patent's claim scope.
Archived snapshot
Mar 31, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Pyrimido pyrimidinone compound and pharmaceutical composition comprising the same
Grant US12590098B2 Kind: B2 Mar 31, 2026
Assignee
AXCESO BIOPHARMA CO., LTD.
Inventors
Young Jun Park, Sung Jun Park, Hyebin Yoo, Hyunnam Song, Si-Eun Yun, Sojin Park, Joon Woo Kim, Sung Il Yoon
Abstract
Diclosed are a pyrimido pyrimidinone compound having an effect of inhibiting PD-L1 expression, a pharmaceutical composition containing the pyrimido pyrimidinone compound as an active ingredient, and uses of the compound or composition. The pyrimido pyrimidinone compound can be effectively used for the treatment or prevention of cancer.
CPC Classifications
C07D 487/04
Filing Date
2021-09-15
Application No.
18245395
Claims
9
Related changes
Get daily alerts for USPTO Patent Grants - Organic Chemistry (C07D)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Organic Chemistry (C07D) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.